OMNY Health Scores $17 million Series B Round to Support Real-World Data Offerings

OMNY Health has announced it has been awarded $17 million in a Series B funding round. The company, which equips provider organizations and other healthcare stakeholders with real-world data (RWD) and real-world evidence (RWE), will use the funding to help support the company’s continued growth and RWD/RWE offerings.

According to PR Newswire, “OMNY’s proprietary DaaS and SaaS solutions spearhead the evolutionary transition to dynamic data procurement and insight generation by seamlessly normalizing data from disparate electronic health record systems across diverse sets of provider sizes and types. As a result, researchers can gain the flexibility they need to acquire fit-for-purpose data that can scale up or down based on their needs. This allows them to significantly reduce data acquisition costs and alleviate the stress of managing multiple data vendors and the compliance activities associated with provider relationships.”

To read more, click here.

(Source: PR Newswire, December 6^th, 2022)